Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohyrates, Petrochemicals) inorganic chemicals), Functionality (Fillers, Diluents, Coatings, Disintegrants), Formulation (Tablet, Capsule, Topical, Parenteral) - Global Forecast to 2025
Click here for an in-depth analysis of the COVID-19 impact on the Pharmaceutical Excipients Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Pharmaceutical Excipients Market
Request Now[300 pages Report] The pharmaceutical excipients market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8%. Factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs, and increasing uptake of biopharmaceuticals, are driving the market for pharmaceutical excipients. The emergence of multifunctional excipients, shifting the focus of pharmaceutical manufacturing to emerging markets, and the growing Biosimilars industry also present significant growth opportunities for market players in the pharmaceutical excipients market.
The organic chemicals segment is to dominate the pharmaceutical excipients market in 2019.
On the basis of product, the pharmaceutical excipients market is segmented into three major categories organic chemicals, inorganic chemicals, and other chemicals. In 2018, the organic chemicals segment accounted for the largest share of the pharmaceutical excipients market. The large share of this segment can be attributed to the use of these chemicals in the majority of pharmaceutical formulations available in the pharmaceutical market.
By functionality, the fillers and diluents segment is expected to account for the largest share of the pharmaceutical excipients market in 2019.
On the basis of functionality, pharmaceutical excipients are categorized into fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants, lubricants & glidants, preservatives, emulsifying agents, and other functionalities. The fillers & diluents segment accounted for the largest share of the pharmaceutical excipients market in 2018. The large share of this segment is attributed to the increased use of fillers and diluents in the development and production of solid oral drugs and the advantages they offer to manufacturers and patients.
By formulation, the oral formulations segment is estimated to account for the largest share of this market in 2019; however, the topical formulations segment is estimated to be the fastest growing segment.
Based on formulation, the pharmaceutical excipients market is segmented into oral, topical, parenteral, and other formulations. In 2018, oral formulations accounted for a major share of the pharmaceutical excipients market, mainly because oral formulations are the most common route of drug delivery.
The market for topical formulations is expected to witness the highest growth during the forecast period. Growth in this segment is majorly due to better assimilation of topical excipients with liquid APIs and increased patient compliance due to sensorial effects.
Europe is expected to hold the largest share of this market in 2019.
The dominant share of this region can be attributed to the presence of a number of pharmaceutical giants with large production capacities leading to high consumption of excipients. The growing emphasis on superior pharmaceutical products, generics, and biosimilars has also led to the increase in the demand for novel excipients, which, in turn, is expected to drive the market growth in this region in the coming years.
Key Market Players
DuPont de Nemours, Inc. (US) and Roquette Feres (France) dominated the global pharmaceutical excipients market in 2018. The prominent players in the global pharmaceutical excipients market are Ashland Global Holdings, Inc. (US), BASF SE (Germany), Evonik Industries AG (Germany), Associated British Foods plc (UK), Archer Daniels Midland Company (US), Lubrizol Corporation(US), and Croda International (UK). Other players in this market are Innophos Holdings (US), Kerry Group plc (Ireland), WACKER Chemie AG (Germany), Colorcon, Inc. (US), DFE Pharma (Germany), JRS Pharma (Germany), and Air Liquide (France).
Roquette (France) is a major player in the market. The company has an extensive product line and has a dominant position, especially in the carbohydrate excipients segment. In this regard, In January 2018, Roquette launched a new carbohydrate excipient product from its facility in India. The company also launched three new excipient brands in March 2017. Roquette (France) has a commercial presence in over 100 countries across North America, Europe, and Asia. It has 30 global establishments, including 20 production sites located across Germany, China, Korea, Spain, the US, France, India, Italy, Romania, and the UK. For its future growth, Roquette intends to further strengthen its existing relationships with key customers by organizing customer meetings, field visits, and training sessions on proactive quality management regularly in order to understand company functionalities and product portfolios better.
Scope of the Report:
|
Report Metric |
Details |
|
Market Size Available for Years |
20172025 |
|
Base Year Considered |
2018 |
|
Forecast Period |
20192025 |
|
Forecast Unit |
Value (USD Billion) |
|
Segments Covered |
Product, Functionality, Formulation |
|
Geographies Covered |
|
|
Companies Covered |
Ashland Global Holdings (US), BASF SE (Germany), DuPont (US), Roquette Feres (France), Evonik Industries AG (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol Corporation (US), and Croda International (UK). Other players in this market are Innophous Holdings (US), Kerry Group (Ireland), WACKER Chemie AG (Germany), Colorcon (US), DFE Pharma (Germany), JRS Pharma (Germany), and Air Liquide (France) |
The research report categorizes the pharmaceutical excipients market into the following segments and subsegments:
Pharmaceutical Excipients Market, by Product
- Organic Chemicals
- Inorganic Chemicals
- Other Devices*
* The other chemicals segment comprises pharmaceutical-grade water and mucilage.
Pharmaceutical Excipients Market, by Functionality
- Fillers and Diluents
- Suspending and Viscosity Agents
- Coating Agents
- Binders
- Flavouring Agents and Sweetners
- Disintegrants
- Colorants
- Lubricants and Glidants
- Preservatives
- Emulsifying Agents
- Other Functionalities
* The other functionalities segment comprises chelating agents, solvents, sorbents, plasticizers, humectants, adsorbents, buffers, wetting agents, anti-foaming agents, anti-adherents, emollients, and acidifying & alkalizing agents.
Pharmaceutical Excipients Market, by Formulation
- Oral Formulations
- Topical Formulations
- Parenteral Formulations
- Other Formulations
* Other formulations mainly include advanced drug formulations where drugs are administered through inhalation, sublingual means, or the use of novel drug delivery means like nanoparticles.
Pharmaceutical Excipients Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- Switzerland
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America
- Middle East & Africa
Recent Developments
- In April 2019, Colorcon, Inc. (US) signed an agreement with DuPont Nutrition and Biosciences (US) in order to enhance the current product portfolio of CR Alliance products.
- In February 2019, Associated British Foods plc (UK) signed an agreement with Indchem International (India) under which, Indchem will distribute Associated British Foods functional lipid excipient product line in the Indian market.
- In January 2019, Croda International (UK) acquired Brenntag Biosector (Denmark) for its vaccine adjuvants portfolio which would be complementary to Crodas pharmaceutical excipients portfolio.
- In December 2018, Roquette Feres (France) signed an agreement with Thermo Fisher Scientific (US), which gives Thermo Fisher the right to distribute the product portfolio of Roquette in the US and Canada.
Key Questions Addressed in the Report
- Who are the top 10 players operating in the pharmaceutical excipients market?
- What are the drivers, restraints, opportunities, and challenges in the pharmaceutical excipients market?
- What are the industry trends as well as the current scenario in the pharmaceutical excipients market?
- What are the growth trends in the pharmaceutical excipients market at the segmental and overall market levels?
- How is the pharmaceutical excipients market performing in different regions across the globe?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 25)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
1.6 Limitations
2 Research Methodology (Page No. - 29)
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary (Page No. - 36)
4 Premium Insights (Page No. - 40)
4.1 Pharmaceutical Excipients: Market Overview
4.2 Pharmaceutical Excipients Market: Geographic Growth Opportunities
4.3 Regional Mix: Pharmaceutical Excipients Market (20192025)
4.4 Asia Pacific: Pharmaceutical Excipients Market Share, By Formulation (2018)
4.5 Pharmaceutical Excipients Market: Developed Vs. Developing Markets (USD Million)
5 Market Overview (Page No. - 45)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growth of the Pharmaceuticals Market Backed By Functional Excipients
5.2.1.2 Surge in the Generics Market
5.2.1.3 Increasing Uptake of Biopharmaceuticals
5.2.1.4 Rising Adoption of Orphan Drugs
5.2.2 Market Restraints
5.2.2.1 Cost and Time-Intensive Drug Development Process
5.2.2.2 Increasing Regulatory Stringency
5.2.3 Market Opportunities
5.2.3.1 Multifunctional Excipients
5.2.3.2 Shifting Focus of Pharmaceutical Manufacturing to Emerging Countries
5.2.3.3 Growth in the Biosimilars Market
5.2.4 Market Challenges
5.2.4.1 Safety and Quality Concerns
5.2.4.2 Changing Trade Policies Between Countries
6 Industry Insights (Page No. - 58)
6.1 Introduction
6.2 Industry Trends
6.2.1 Rising Demand and Emphasis on Co-Processed Excipients
6.2.2 Improving Excipient Capabilities By Using Nanotechnology
6.2.3 Increasing use of Direct Compression in Oral Dosage Formulations
6.2.4 Pharmaceutical Excipients Influencing the Cost of Production
6.3 Regulatory Analysis
6.3.1 North America
6.3.1.1 US
6.3.1.2 Canada
6.3.2 Europe
6.3.3 Asia Pacific
6.3.3.1 Japan
6.3.3.2 China
6.3.3.3 India
7 Pharmaceutical Excipients Market, By Product (Page No. - 68)
7.1 Introduction
7.2 Organic Chemicals
7.2.1 Oleochemicals
7.2.1.1 Increasing Demand for Environmentally Friendly Excipients to Drive the Growth of This Market
7.2.1.2 Fatty Alcohols
7.2.1.3 Mineral Stearates
7.2.1.4 Glycerin
7.2.1.5 Other Oleochemicals
7.2.2 Carbohydrates
7.2.2.1 Increasing Application of Carbohydrates in New Drug Delivery Forms to Boost Market Growth
7.2.2.2 Sugars
7.2.2.2.1 Actual Sugars
7.2.2.2.1.1 Lactose
7.2.2.2.1.2 Sucrose
7.2.2.2.1.3 Dextrose (D-Glucose)
7.2.2.2.2 Sugar Alcohols
7.2.2.2.2.1 Mannitol
7.2.2.2.2.2 Sorbitol
7.2.2.2.2.3 Other Sugar Alcohols
7.2.2.2.3 Artificial Sweeteners
7.2.2.3 Cellulose
7.2.2.3.1 Microcrystalline Cellulose
7.2.2.3.2 Cellulose Ethers
7.2.2.3.3 CMC and Croscarmellose Sodium
7.2.2.3.4 Cellulose Esters
7.2.2.4 Starch
7.2.2.4.1 Modified Starch
7.2.2.4.2 Dried Starch
7.2.2.4.3 Converted Starch
7.2.3 Petrochemicals
7.2.3.1 Glycols
7.2.3.1.1 Glycols are the Most Widely Used Petrochemical Excipients for Pharmaceutical Applications
7.2.3.1.2 Polyethylene Glycol
7.2.3.1.3 Propylene Glycol
7.2.3.2 Povidones
7.2.3.2.1 Rising Demand for Fast-Dissolving Tablets is Expected to Propel the Market for Povidones
7.2.3.3 Mineral Hydrocarbons
7.2.3.3.1 High Adoption in Topical Formulations to Drive Market Growth
7.2.3.3.2 PetRoLAtum
7.2.3.3.3 Mineral Waxes
7.2.3.3.4 Mineral Oils
7.2.3.4 Acrylic Polymers
7.2.3.4.1 Wide use of Acrylic Polymers in Controlled-Release Drug Formulations to Drive the Growth of This Market
7.2.3.5 Other Petrochemicals
7.2.4 Proteins
7.2.4.1 Rising Application of Proteins as Carriers for Microparticles and Nanoparticles to Drive This Market
7.2.5 Other Organic Chemicals
7.3 Inorganic Chemicals
7.3.1 Calcium Phosphate
7.3.1.1 Chemical Purity and Low Incompatibility With Drugs Aid Their High Usage in the Pharmaceutical Industry
7.3.2 Metal Oxides
7.3.2.1 Availability of Silicon Oxides in the Hydrophobic, Hydrophilic, and Granulated Forms to Aid Market Growth
7.3.3 Halites
7.3.3.1 Increased Utilization of Halites in Vaccines as Well as Controlled-Release Formulations is Driving Their Demand in the Market
7.3.4 Calcium Carbonate
7.3.4.1 Properties Such as Short Disintegration Time and Excellent Mechanical Strength for Oral Dosage Formulations to Drive the Market
7.3.5 Calcium Sulfate
7.3.5.1 Calcium Sulfate is a Cost-Effective, Quality Enhancing Diluent for Solid Dosage Forms
7.3.6 Other Inorganic Chemicals
7.4 Other Chemicals
8 Pharmaceutical Excipients Market, By Functionality (Page No. - 116)
8.1 Introduction
8.2 Fillers & Diluents
8.2.1 Diluents Offer Properties Such as Improved Cohesion, Direct Compression, and Flow to the Final Dose in Tablets
8.3 Suspending & Viscosity Agents
8.3.1 Suspensions Offer Advantages Such as Drug Stability, Masked Taste of Insoluble Ingredients, and Prolonged Drug Action
8.4 Coating Agents
8.4.1 The Increasing Utilization of Sustained-Release Formulations in the Pharmaceutical Industry is Driving This Market Segment
8.5 Binders
8.5.1 Binders Provide the Properties of Fluidity and Compressibility That are Essential for Tablet Manufacturing
8.6 Flavoring Agents & Sweeteners
8.6.1 Flavoring Agents are Used to Improve the Palatability of Drugs
8.7 Disintegrants
8.7.1 Disintegrants Allow Tablets and Capsules to Pack a Powerful Portion of Medications in a Small Form That is Easier to Ingest
8.8 Colorants
8.8.1 Coloring Agents are Used in Hard and Soft Gelatin Capsules, Tablets, Oral Liquids, and Topical Creams
8.9 Lubricants & Glidants
8.9.1 Glidants Improve the Flow Properties of a Formulation By Reducing Interparticle Friction and Cohesion
8.10 Preservatives
8.10.1 Benzyl Alcohol is a Widely Used Preservative in the Pharmaceutical and Nutraceutical Industry
8.11 Emulsifying Agents
8.11.1 The use of Solubility Enhancement Excipients in Liquid Drug Formulations Helps Increase the Bioavailability of the Api
8.12 Other Functionalities
9 Pharmaceutical Excipients Market, By Type of Formulation (Page No. - 137)
9.1 Introduction
9.2 Oral Formulations
9.2.1 High Preference for Oral Route and Growing Focus on Novel Oral Drug Delivery Systems is Driving Market Growth
9.2.2 Tablets
9.2.3 Capsules
9.2.3.1 Hard Gelatin Capsules
9.2.3.2 Soft Gelatin Capsules
9.2.4 Liquid Formulations
9.3 Topical Formulations
9.3.1 Advantages of Topical Drug Delivery are Driving Demand for Excipients in This Segment
9.4 Parenteral Formulations
9.4.1 Emergence of New Biological Molecules to Increase the Demand for Excipients
9.5 Other Formulations
10 Pharmaceutical Excipients Market, By Region (Page No. - 153)
10.1 Introduction
10.2 Europe
10.2.1 Germany
10.2.1.1 Germany Accounted for the Largest Share of the Market in 2018
10.2.2 France
10.2.2.1 Stringent Policies to Support Innovation Pose Regulatory Challenges for the Pharmaceutical Excipients Market in France
10.2.3 UK
10.2.3.1 Growing Adoption of Generics and the Development of Novel Multi-Functional Co-Processed Excipients to Drive Market Growth
10.2.4 Switzerland
10.2.4.1 Large Volume of Pharmaceuticals Produced in Switzerland Provides Huge Potential for the Utilization of Pharmaceutical Excipients
10.2.5 Italy
10.2.5.1 Budgetary Constraints and Restricted Healthcare Spending to Impede the Growth of the Italian Market
10.2.6 Spain
10.2.6.1 High Consumption of Biologics to Support Market Growth
10.2.7 Rest of Europe
10.3 North America
10.3.1 US
10.3.1.1 The US Dominates the North American Market Due to the Increasing use of Biologics and the Increasing Per Capita Pharmaceutical Spending
10.3.2 Canada
10.3.2.1 Strong Growth of the Emerging Markets and Slowdown in New Product Approvals to Hamper Market Growth in Canada
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Rapid Growth of Japans Geriatric Population Will Greatly Drive the Demand for Pharmaceuticals
10.4.2 China
10.4.2.1 Chinese Government has Emphasized Generics and Off-Patent Drugs
10.4.3 India
10.4.3.1 India is a Leading Producer of Generics
10.4.4 South Korea
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Growing Geriatric Population and Disease Prevalence are Driving Market Growth
10.6 Middle East and Africa
10.6.1 Unsaturated Markets in This Region Have Drawn the Attention of Global Players
11 Competitive Landscape (Page No. - 222)
11.1 Introduction
11.2 Geographical Assessment of Major Players in the Pharmaceutical Excipients Market
11.3 Competitive Leadership Mapping
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Dynamic Differentiators
11.3.4 Emerging Companies
11.4 Market Share Analysis
11.4.1 Pharmaceutical Excipients Market Share Analysis, 2018
11.5 Competitive Assessment of R&D Expenditure
11.6 Competitive Situations and Trends
12 Company Profiles (Page No. - 233)
(Business Overview, Products Offered, Recent Developments, MnM View, SWOT Analysis)*
12.1 Dupont De Nemours, Inc.
12.2 Roquette Frθres
12.3 Ashland Global Holdings Inc.
12.4 Evonik Industries AG
12.5 BASF SE
12.6 Kerry Group PLC
12.7 Croda International
12.8 Associated British Foods PLC
12.9 Archer Daniels Midland Company
12.10 Lubrizol Corporation
12.11 Innophos Holdings Inc.
12.12 WACKER Chemie AG
12.13 Air Liquide S.A.
12.14 Colorcon Inc.
12.15 DMV-Fonterra Excipients GmbH & Co. Kg
12.16 JRS Pharma GmbH & Co. Kg
*Business Overview, Products Offered, Recent Developments, MnM View, SWOT Analysis Might Not be Captured in Case of Unlisted Companies.
13 Appendix (Page No. - 290)
13.1 Insights of Industry Experts
13.2 Market Sizing & Validation Approach
13.3 Discussion Guide
13.4 Knowledge Store: Marketsandmarkets Subscription Portal
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details
List of Tables (220 Tables)
Table 1 Drugs Coming Off-Patent
Table 2 Key Market Drivers: Impact Analysis
Table 3 Key Market Restraints: Impact Analysis
Table 4 Multifunctional Excipients
Table 5 Clinical Studies for Biologics & Biosimilars (2017)
Table 6 Key Market Opportunities: Impact Analysis
Table 7 Key Market Challenges: Impact Analysis
Table 8 Marketed Co-Processed Excipients
Table 9 Pharmaceutical Excipients: Market, By Product, 20172025 (USD Million)
Table 10 Pharmaceutical Excipients: Market, By Country, 20172025 (USD Million)
Table 11 Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 12 Organic Chemicals Market, By Country, 20172025 (USD Million)
Table 13 Oleochemicals Market, By Type, 20172025 (USD Million)
Table 14 Oleochemicals Market, By Country, 20172025 (USD Million)
Table 15 Oleochemicals: Key Brands
Table 16 Fatty Alcohols Market, By Country, 20172025 (USD Million)
Table 17 Mineral Stearates Market, By Country, 20172025 (USD Million)
Table 18 Glycerin Market, By Country, 20172025 (USD Million)
Table 19 Other Oleochemicals Market, By Country, 20172025 (USD Million)
Table 20 Carbohydrates Market, By Type, 20172025 (USD Million)
Table 21 Carbohydrates Market, By Country, 20172025 (USD Million)
Table 22 Carbohydrates: Key Brands
Table 23 Sugars Market, By Type, 20172025 (USD Million)
Table 24 Sugars Market, By Country, 20172025 (USD Million)
Table 25 Actual Sugars Market, By Type, 20172025 (USD Million)
Table 26 Actual Sugars Market, By Country, 20172025 (USD Million)
Table 27 Sugar Alcohols Market, By Type, 20172025 (USD Million)
Table 28 Sugar Alcohols Market, By Country, 20172025 (USD Million)
Table 29 Artificial Sweeteners Market, By Country, 20172025 (USD Million)
Table 30 Cellulose Market, By Type, 20172025 (USD Million)
Table 31 Cellulose Market, By Country, 20172025 (USD Million)
Table 32 Microcrystalline Cellulose Market, By Country, 20172025 (USD Million)
Table 33 Cellulose Ethers Market, By Country, 20172025 (USD Million)
Table 34 CMC & Croscarmellose Sodium Market, By Country, 20172025 (USD Million)
Table 35 Cellulose Esters Market, By Country, 20172025 (USD Million)
Table 36 Starch Market, By Type, 20172025 (USD Million)
Table 37 Starch Market, By Country, 20172025 (USD Million)
Table 38 Modified Starch Market, By Country, 20172025 (USD Million)
Table 39 Dried Starch Market, By Country, 20172025 (USD Million)
Table 40 Converted Starch Market, By Country, 20172025 (USD Million)
Table 41 Petrochemicals Market, By Type, 20172025 (USD Million)
Table 42 Petrochemicals Market, By Country, 20172025 (USD Million)
Table 43 Petrochemicals: Key Brands
Table 44 Glycols Market, By Type, 20172025 (USD Million)
Table 45 Glycols Market, By Country, 20172025 (USD Million)
Table 46 Povidones Market, By Country, 20172025 (USD Million)
Table 47 Mineral Hydrocarbons Market, By Type, 20172025 (USD Million)
Table 48 Mineral Hydrocarbons Market, By Country, 20172025 (USD Million)
Table 49 Acrylic Polymers Market, By Country, 20172025 (USD Million)
Table 50 Other Petrochemicals Market, By Country, 20172025 (USD Million)
Table 51 Proteins Market, By Country, 20172025 (USD Million)
Table 52 Proteins: Key Brands
Table 53 Other Organic Chemicals Market, By Country, 20172025 (USD Million)
Table 54 Other Organic Chemicals: Key Brands
Table 55 Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 56 Inorganic Chemicals Market, By Country, 20172025 (USD Million)
Table 57 Inorganic Chemicals: Key Brands
Table 58 Calcium Phosphate Market, By Country, 20172025 (USD Million)
Table 59 Metal Oxides Market, By Country, 20172025 (USD Million)
Table 60 Halites Market, By Country, 20172025 (USD Million)
Table 61 Calcium Carbonate Market, By Country, 20172025 (USD Million)
Table 62 Calcium Sulfate Market, By Country, 20172025 (USD Million)
Table 63 Other Inorganic Chemicals Market, By Country, 20172025 (USD Million)
Table 64 Other Chemicals Market, By Country, 20172025 (USD Million)
Table 65 Other Chemicals: Key Brands
Table 66 Pharmaceutical Excipients: Market, By Functionality, 20172025 (USD Million)
Table 67 Pharmaceutical Excipients: Market for Fillers & Diluents, By Country/Region, 20172025 (USD Million)
Table 68 Excipients for Fillers and Diluents
Table 69 Pharmaceutical Excipients: Market for Suspending & Viscosity Agents, By Country/Region, 20172025 (USD Million)
Table 70 Excipients for Suspending and Viscosity Agents
Table 71 Pharmaceutical Excipients: Market for Coating Agents, By Country/Region, 20172025 (USD Million)
Table 72 Excipients for Coating Agents
Table 73 Pharmaceutical Excipients: Market for Binders, By Country/Region, 20172025 (USD Million)
Table 74 Excipients for Binders
Table 75 Pharmaceutical Excipients: Market for Flavoring Agents & Sweeteners, By Country/Region, 20172025 (USD Million)
Table 76 Excipients for Flavoring Agents
Table 77 Pharmaceutical Excipients: Market for Disintegrants, By Country/Region, 20172025 (USD Million)
Table 78 Excipients for Disintegrants
Table 79 Pharmaceutical Excipients: Market for Colorants, By Country/Region, 20172025 (USD Million)
Table 80 Excipients for Colorants
Table 81 Pharmaceutical Excipients: Market for Lubricants & Glidants, By Country/Region, 20172025 (USD Million)
Table 82 Excipients for Lubricants and Glidants
Table 83 Pharmaceutical Excipients: Market for Preservatives, By Country/Region, 20172025 (USD Million)
Table 84 Excipients for Preservatives
Table 85 Pharmaceutical Excipients: Market for Emulsifying Agents, By Country/Region, 20172025 (USD Million)
Table 86 Excipients for Emulsifying Agents
Table 87 Other Functionalities Market, By Country/Region, 20172025 (USD Million)
Table 88 Excipients for Other Functionalities
Table 89 Pharmaceutical Excipients: Market, By Formulation, 20172025 (USD Million)
Table 90 Excipients for Oral Formulations
Table 91 Pharmaceutical Excipients: Market for Oral Formulations, By Type, 20172025 (USD Million)
Table 92 Pharmaceutical Excipients: Market for Oral Formulations, By Country, 20172025 (USD Million)
Table 93 Typical Composition of Tablets
Table 94 Pharmaceutical Excipients: Market for Tablets, By Country, 20172025 (USD Million)
Table 95 Market for Capsules, By Type, 20172025 (USD Million)
Table 96 Market for Capsules, By Country, 20172025 (USD Million)
Table 97 Market for Hard Gelatin Capsules, By Country, 20172025 (USD Million)
Table 98 Market for Soft Gelatin Capsules, By Country, 20172025 (USD Million)
Table 99 Market for Liquid Formulations, By Country, 20172025 (USD Million)
Table 100 Excipients for Topical Formulations
Table 101 Market for Topical Formulations, By Country, 20172025 (USD Million)
Table 102 Typical Composition of Parenteral Formulations
Table 103 Excipients Used in Parenteral Formulations
Table 104 Market for Parenteral Formulations, By Country, 20172025 (USD Million)
Table 105 Market for Other Formulations, By Country, 20172025 (USD Million)
Table 106 Market, By Region, 20172025 (USD Million)
Table 107 Europe: Market, By Country, 20172025 (USD Million)
Table 108 Europe: Market, By Product, 20172025 (USD Million)
Table 109 Europe: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 110 Europe: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 111 Europe: Market, By Functionality, 20172025 (USD Million)
Table 112 Europe: Market, Formulation, 20172025 (USD Million)
Table 113 Germany: Key Microindicators
Table 114 Germany: Market, By Product, 20172025 (USD Million)
Table 115 Germany: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 116 Germany: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 117 Germany: Market, By Functionality, 20172025 (USD Million)
Table 118 Germany: Market, Formulation, 20172025 (USD Million)
Table 119 France: Key Microindicators
Table 120 France: Market, By Product, 20172025 (USD Million)
Table 121 France: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 122 France: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 123 France: Market, By Functionality, 20172025 (USD Million)
Table 124 France: Market, Formulation, 20172025 (USD Million)
Table 125 UK: Key Microindicators
Table 126 UK: Market, By Product, 20172025 (USD Million)
Table 127 UK: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 128 UK: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 129 UK: Market, By Functionality, 20172025 (USD Million)
Table 130 UK: Market, By Formulation, 20172025 (USD Million)
Table 131 Switzerland: Key Microindicators
Table 132 Switzerland: Market, By Product, 20172025 (USD Million)
Table 133 Switzerland: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 134 Switzerland: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 135 Switzerland: Market, By Functionality, 20172025 (USD Million)
Table 136 Switzerland: Market, Formulation, 20172025 (USD Million)
Table 137 Italy: Key Microindicators
Table 138 Italy: Market, By Product, 20172025 (USD Million)
Table 139 Italy: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 140 Italy: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 141 Italy: Market, By Functionality, 20172025 (USD Million)
Table 142 Italy: Market, Formulation, 20172025 (USD Million)
Table 143 Spain: Key Microindicators
Table 144 Spain: Market, By Product, 20172025 (USD Million)
Table 145 Spain: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 146 Spain: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 147 Spain: Market, By Functionality, 20172025 (USD Million)
Table 148 Spain: Market, By Formulation, 20172025 (USD Million)
Table 149 RoE: Market, By Product, 20172025 (USD Million)
Table 150 RoE: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 151 RoE: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 152 RoE: Market, By Functionality, 20172025 (USD Million)
Table 153 RoE: Market, By Formulation, 20172025 (USD Million)
Table 154 North America: Market, By Country, 20172025 (USD Million)
Table 155 North America: Market, By Product, 20172025 (USD Million)
Table 156 North America: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 157 North America: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 158 North America: Market, By Functionality, 20172025 (USD Million)
Table 159 North America: Market, By Formulation, 20172025 (USD Million)
Table 160 US: Key Microindicators
Table 161 US: Market, By Product, 20172025 (USD Million)
Table 162 US: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 163 US: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 164 US: Market, By Functionality, 20172025 (USD Million)
Table 165 US: Market, By Formulation, 20172025 (USD Million)
Table 166 Canada: Key Microindicators
Table 167 Canada: Market, By Product, 20172025 (USD Million)
Table 168 Canada: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 169 Canada: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 170 Canada: Market, By Functionality, 20172025 (USD Million)
Table 171 Canada: Market, By Formulation, 20172025 (USD Million)
Table 172 Asia Pacific: Market, By Country, 20172025 (USD Million)
Table 173 Asia Pacific: Market, By Product, 20172025 (USD Million)
Table 174 Asia Pacific: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 175 Asia Pacific: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 176 Asia Pacific: Market, By Functionality, 20172025 (USD Million)
Table 177 Asia Pacific: Market, By Formulation, 20172025 (USD Million)
Table 178 Japan: Key Microindicators
Table 179 Japan: Market, By Product, 20172025 (USD Million)
Table 180 Japan: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 181 Japan: Inorganic Chemicals Market, By Type, 2017, 20172025 (USD Million)
Table 182 Japan: Market, By Functionality, 20172025 (USD Million)
Table 183 Japan: Market, By Formulation, 20172025 (USD Million)
Table 184 China: Key Microindicators
Table 185 China: Market, By Product, 20172025 (USD Million)
Table 186 China: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 187 China: Inorganic Chemicals Market, By Type, 2017, 20172025 (USD Million)
Table 188 China: Market, By Functionality, 20172025 (USD Million)
Table 189 China: Market, By Formulation, 20172025 (USD Million)
Table 190 India: Key Microindicators
Table 191 India: Market, By Product, 20172025 (USD Million)
Table 192 India: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 193 India: Inorganic Chemicals Market, By Type, 2017, 20172025 (USD Million)
Table 194 India: Market, By Functionality, 20172025 (USD Million)
Table 195 India: Market, By Formulation, 20172025 (USD Million)
Table 196 South Korea: Market, By Product, 20172025 (USD Million)
Table 197 South Korea: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 198 South Korea: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 199 South Korea: Market, By Functionality, 20172025 (USD Million)
Table 200 South Korea: Market, By Formulation, 20172025 (USD Million)
Table 201 RoAPAC: Market, By Product, 20172025 (USD Million)
Table 202 RoAPAC: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 203 RoAPAC: Inorganic Chemicals Market, By Type, 2017, 20172025 (USD Million)
Table 204 RoAPAC: Market, By Functionality, 20172025 (USD Million)
Table 205 RoAPAC: Market, By Formulation, 20172025 (USD Million)
Table 206 Latin America: Market, By Product, 20172025 (USD Million)
Table 207 Latin America: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 208 Latin America: Inorganic Chemicals Market, By Type, 2017, 20172025 (USD Million)
Table 209 Latin America: Market, By Functionality, 20172025 (USD Million)
Table 210 Latin America: Market, By Formulation, 20172025 (USD Million)
Table 211 Middle East and Africa: Market, By Product, 20172025 (USD Million)
Table 212 Middle East and Africa: Organic Chemicals Market, By Type, 20172025 (USD Million)
Table 213 Middle East and Africa: Inorganic Chemicals Market, By Type, 20172025 (USD Million)
Table 214 Middle East and Africa: Market, By Functionality, 20172025 (USD Million)
Table 215 Middle East and Africa: Market, By Formulation, 20172025 (USD Million)
Table 216 Product Launches (2018-2019)
Table 217 Mergers and Acquisitions (2017-2019)
Table 218 Agreements and Partnerships (2018-2019)
Table 219 Expansions (2018-2019)
Table 220 Other Developments (2016-2018)
List of Figures (50 Figures)
Figure 1 Global Pharmaceutical Excipients Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designations, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Pharmaceutical Excipients Market, By Product, 2019 Vs. 2025 (USD Million)
Figure 8 Organic Chemicals Market, By Type, 2019 Vs. 2025 (USD Million)
Figure 9 Pharmaceutical Excipients Market, By Functionality, 2019 Vs. 2025 (USD Million)
Figure 10 Pharmaceutical Excipients Market, By Formulation, 2019 Vs. 2025 (USD Million)
Figure 11 Geographical Snapshot: Pharmaceutical Excipients Market
Figure 12 Growing Pharmaceuticals Industry Coupled With Advancements in Functional Excipients are Key Factors Driving Market Growth
Figure 13 Asia Pacific is Projected to Show the Highest Revenue Growth During the Forecast Period
Figure 14 Europe to Hold the Largest Share of the Market During the Forecast Period (20182023)
Figure 15 Oral Formulation Accounted for the Largest Share of the Asia Pacific Market in 2018
Figure 16 Developing Markets to Register a Higher Growth Rate During the Forecast Period
Figure 17 Pharmaceutical Excipients Market: Drivers, Restraints, Opportunities, & Challenges
Figure 18 Global Pharmaceutical Drug Sales (20082022)
Figure 19 Growth of the Generics Market, 2006 vs 2016
Figure 20 Increasing Penetration of Orphan Drugs (20102024)
Figure 21 Rising Number of Orphan Indications Approved in the US
Figure 22 Estimated Pre-Approval Cost of Bringing a New Chemical or Biological Entity to Market (19702010)
Figure 23 Total Number of New Molecular Entity (NME) & New Biologic License Application (BLA) Filings and Approvals in the US, 20062018
Figure 24 Increasing Focus on Co-Processed Excipients and use of Nanotechnology in Excipient Production are the Leading Trends in the Industry
Figure 25 Organic Chemicals Segment to Dominate the Pharmaceutical Excipients Market in 2019
Figure 26 Oleochemicals are Expected to Dominate the Organic Chemicals Market During the Forecast Period
Figure 27 Pharmaceutical Excipients Market, By Functionality, 2019 Vs. 2025
Figure 28 Oral Formulations to Form the Largest Segment in the Pharmaceutical Excipients Market During the Forecast Period
Figure 29 Pharmaceutical Excipients Market: Geographic Snapshot
Figure 30 Europe Pharmaceutical Production, 2015 Vs. 2016 (USD Billion)
Figure 31 Europe: Pharmaceutical Excipients Market Snapshot
Figure 32 North America: Pharmaceutical Excipients Market Snapshot
Figure 33 Asia Pacific: Pharmaceutical Excipients Market Snapshot
Figure 34 Key Developments in the Pharmaceutical Excipients Market Between 2016 and 2019
Figure 35 Geographical Revenue Mix: Pharmaceutical Excipients Market (2018)
Figure 36 Pharmaceutical Excipients Market: Competitive Leadership Mapping (2018)
Figure 37 Pharmaceutical Excipients Market Share Analysis, By Key Player (2018)
Figure 38 R&D Expenditure: Major Players in the Pharmaceutical Excipients Market 2017 & 2018
Figure 39 DuPont De Nemours, Inc.: Company Snapshot (2018)
Figure 40 Roquette Frθres: Company Snapshot (2018)
Figure 41 Ashland Global Holdings Inc.: Company Snapshot (2018)
Figure 42 Evonik Industries AG: Company Snapshot (2018)
Figure 43 BASF SE: Company Snapshot (2018)
Figure 44 Kerry Group PLC: Company Snapshot (2018)
Figure 45 Croda International: Company Snapshot (2018)
Figure 46 Associated British Foods PLC: Company Snapshot (2018)
Figure 47 Archer Daniels Midland Company: Company Snapshot (2018)
Figure 48 Innophos Holdings Inc: Company Snapshot (2018)
Figure 49 WACKER Chemie AG: Company Snapshot (2018)
Figure 50 Air Liquide S.A.: Company Snapshot (2018)
The study involved 4 major activities in estimating the current market size for pharmaceutical excipients market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
Secondary Research
This research study involved the use of widespread secondary sources; directories; databases such as D&B Hoovers, Bloomberg Business, and Factiva; white papers; annual reports; companies house documents; and SEC filings. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global pharmaceutical excipients market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, key developments related to market, and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies operating in the pharmaceutical excipients market. The primary sources from the demand side include experts from drugs manufacturing companies and contract manufacturing organizations.
Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and burning issues, and key market dynamics such as market drivers, challenges, and opportunities.
To know about the assumptions considered for the study, download the pdf brochure
Market Share Estimation
The market shares for leading pharmaceutical excipients manufacturing companies was arrived at after detailed assessment of their revenues from the pharmaceutical excipients business by secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases revenue share was arrived at after detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with various industry experts.
Data Triangulation
After arriving at the overall market sizeusing the market size estimation processes as explained abovethe market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides.
Objectives of the Study
- To define, describe, segment, and forecast the global pharmaceutical excipients market on the basis of product, functionality, formulation, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and industry-specific challenges)
- To analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall pharmaceutical excipients market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of the pharmaceutical excipients market, in five main regions (along with major countries)North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa
- To profile key players in the global pharmaceutical excipients market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as mergers and acquisitions; new product/technology launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global pharmaceutical excipients market
Available customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific pharmaceutical excipients market into Australia, New Zealand, and others
- Further breakdown of the Latin American pharmaceutical excipients market into Brazil, Mexico, and others
Company Information
- Detailed analysis and profiling of additional market players
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Excipients Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Pharmaceutical Excipients Market
Polyethylene oxide (PEO) is more commonly known as Polyethylene glycol (PEG) or poly(oxyethylene). The market for PEG has been provided under Section 7.2.3.1.1 of the Pharmaceutical Excipients Market report.
This report does not list Polyethylene Oxide.